Myelodysplastic syndromes (MDSs) are chronic and often progressive myeloid neoplasms
associated with remarkable heterogeneity in the histomorphology and clinical course. …

Most cases of adult myeloid neoplasms are routinely assumed to be sporadic. Here, we
describe an adult familial acute myeloid leukemia (AML) syndrome caused by germline …

Chronic lymphoproliferative disorders of natural killer cells (CLPD-NKs) and T-cell large
granular lymphocytic leukemias (T-LGLs) are clonal lymphoproliferations arising from either …

To elucidate differential roles of mutations in myelodysplastic syndromes (MDS), we
investigated clonal dynamics using whole-exome and/or targeted sequencing of 699 patients, of …

Mutations in the TET2 gene are frequent in myeloid disease, although their biologic and
prognostic significance remains unclear. We analyzed 355 patients with myelodysplastic …

Genetic alterations, including mutations and copy-number alterations, are central to the
pathogenesis of myelodysplastic syndromes and related diseases (myelodysplasia), but their …

Somatic cohesin mutations have been reported in myelodysplastic syndrome (MDS) and
acute myeloid leukemia (AML). To account for the morphologic and cytogenetic diversity of …

Here we report whole-exome sequencing of individuals with various myeloid malignancies
and identify recurrent somatic mutations in SETBP1, consistent with a recent report on …

The splicing factor SF3B1 is the most commonly mutated gene in the myelodysplastic syndrome
(MDS), particularly in patients with refractory anemia with ring sideroblasts (RARS). We …

Recently, recurrent mutations of spliceosomal genes were frequently identified in myeloid
malignancies, as well as other types of cancers. One of these spliceosomal genes, U2AF1, …